Fmr LLC Raises Holdings in Senseonics Holdings, Inc. (NYSE:SENS)

Fmr LLC increased its position in Senseonics Holdings, Inc. (NYSE:SENS) by 48,267.2% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 168,318 shares of the company’s stock after purchasing an additional 167,970 shares during the period. Fmr LLC’s holdings in Senseonics were worth $59,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. GSA Capital Partners LLP purchased a new stake in Senseonics in the third quarter valued at approximately $117,000. Cubist Systematic Strategies LLC increased its holdings in shares of Senseonics by 25.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after acquiring an additional 85,501 shares during the period. Finally, Symmetry Partners LLC purchased a new stake in Senseonics in the 3rd quarter valued at $164,000. 12.36% of the stock is owned by institutional investors and hedge funds.

Senseonics Price Performance

Shares of SENS opened at $0.48 on Wednesday. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The stock’s 50 day moving average is $0.34 and its two-hundred day moving average is $0.38. Senseonics Holdings, Inc. has a twelve month low of $0.25 and a twelve month high of $0.75. The firm has a market capitalization of $283.26 million, a PE ratio of -3.66 and a beta of 0.77.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. StockNews.com started coverage on Senseonics in a research note on Wednesday, December 18th. They set a “sell” rating for the company. HC Wainwright restated a “buy” rating and issued a $2.00 target price on shares of Senseonics in a research note on Friday, November 15th.

Insider Activity at Senseonics

In related news, CEO Timothy T. Goodnow bought 315,000 shares of the stock in a transaction on Tuesday, December 10th. The shares were bought at an average cost of $0.31 per share, for a total transaction of $97,650.00. Following the completion of the transaction, the chief executive officer now owns 11,310,355 shares of the company’s stock, valued at $3,506,210.05. This represents a 2.86 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Frederick T. Sullivan bought 124,933 shares of the company’s stock in a transaction on Thursday, December 12th. The stock was bought at an average cost of $0.38 per share, with a total value of $47,474.54. Following the completion of the acquisition, the chief financial officer now owns 2,478,844 shares of the company’s stock, valued at $941,960.72. This represents a 5.31 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 3.60% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.